Publication:
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group

Thumbnail Image

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Yeşilkaya, A.
Menekşe, Güler Ö.
Karakoç, Ç.
Çınar, G.
Aydın, M.
Keske, Şahin, S.
Hacıseyitoğlu, D.
Yalçın, D.
Albayrak, Ö.
Can, F.

Publication Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

This study aimed to describe the effect of initial antifungal therapy on patient mortality and to detail the current distribution and resistance patterns of Candida spp. among patients with candidaemia. A prospective observational study was performed among consecutive patients with candidaemia from 10 Turkish medical centres between January 2015 and November 2018. The primary outcome was 10-day mortality. Species were identified using MALDI-TOF/MS. A total of 342 patients with candidaemia were included, of which 175 (51.2%) were male and 68 (19.9%) were aged <18 years. The most common species were Candida albicans (47.4%), Candida parapsilosis (26.6%), Candida tropicalis (9.6%) and Candida glabrata (7.6%). Among all Candida spp., the 10-day case fatality rate (CFR) was 32.2%. The CFR was highest in patients with C. albicans (57.3%) and lowest in patients with C. parapsilosis (21.8%). The resistance rate to fluconazole was 13% in C. parapsilosis, with no significant effect on mortality. No resistance to echinocandins was detected. In the multivariate analysis, being in the ICU [OR = 2.1 (95% CI 1.32–3.57); P = 0.002], renal failure [OR = 2.4 (1.41–3.97); P = 0.001], total parenteral nutrition [OR = 2 (1.22–3.47); P = 0.006], C. albicans infection [OR = 1.7 (1.06–2.82); P = 0.027] and echinocandin as primary agent [OR = 0.6 (0.36–0.99); P = 0.047] were significantly associated with mortality. Candidaemia is a deadly infection. Fluconazole resistance is emerging, although it was not significantly related to mortality. Using an echinocandin as the primary agent could be life-saving.

Source

Publisher

Elsevier

Subject

Medicine, Invasive candidiasis, Candida parapsilosis

Citation

Has Part

Source

International Journal of Antimicrobial Agents

Book Series Title

Edition

DOI

10.1016/j.ijantimicag.2020.105992

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

1

Downloads

View PlumX Details